Use code RJTJFG for 20% off at checkout. Until 5/31/20
Boundary: Bleed area may not be visible.
by Eye of Science
$54.00
This product is currently out of stock.
Size
Orientation
Image Size
Product Details
You'll never run out of power again! If the battery on your smartphone or tablet is running low... no problem. Just plug your device into the USB port on the top of this portable battery charger, and then continue to use your device while it gets recharged.
With a recharge capacity of 5200 mAh, this charger will give you 1.5 full recharges of your smartphone or recharge your tablet to 50% capacity.
When the battery charger runs out of power, just plug it into the wall using the supplied cable (included), and it will recharge itself for your next use.
Design Details
Color enhanced scanning electron microscope image of a CAR-T lymphocyte (beige) attacks a leukemia cell (red). CAR-T lymphocytes are used for... more
Dimensions
1.80" W x 3.875" H x 0.90" D
Ships Within
1 - 2 business days
Photograph
Canvas Print
Framed Print
Art Print
Poster
Metal Print
Acrylic Print
Wood Print
Greeting Card
iPhone Case
Throw Pillow
Duvet Cover
Shower Curtain
Tote Bag
Round Beach Towel
Zip Pouch
Beach Towel
Weekender Tote Bag
Portable Battery Charger
Bath Towel
Apparel
Coffee Mug
Yoga Mat
Spiral Notebook
Fleece Blanket
Tapestry
Jigsaw Puzzle
Sticker
Ornament
Color enhanced scanning electron microscope image of a CAR-T lymphocyte (beige) attacks a leukemia cell (red). CAR-T lymphocytes are used for immunotherapy against cancer (CAR stands for chimeric antigen receptor). T cells are taken from the patient and genetically modified to carry a chimeric antigen receptor. After the proliferation of the CAR-expressing T cells, they are transfused back into the patient and can directly detect the cancer cells carrying the antigen. The binding of a CAR-T cell to a tumor cell initiates an appropriate immune defense. Magnification is 5335x at 10 cm wide.
$54.00
There are no comments for Leukemia Cell With Car T-cell, Sem. Click here to post the first comment.